Akesion - One Solution
Of patients who undergo abdominal surgery, over 50% develop adverse adhesions between organs. Adhesions often lead to pain, infertility and, in severe cases, to life-threatening bowel obstruction. A new drug developed by the startup company Akesion removes the main precursor of these adhesions preventing the formation of adhesions as well as risky repeat surgeries that are stressful to patients.
LicenseDefault alugha License
More videos by this producer
The roughly 3-minute film provides an initial impression of the MAHLE plant and also presents the principles and values that govern the way the team works together on a daily basis. And, of course, it highlights the innovative technologies that find application in the MAHLE thermal management produc